HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
QDEL
QuidelOrtho Corporation
QDEL lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
QDEL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
QDEL's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
QDEL PE Valuation
QDEL has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
QDEL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect QDEL's profitability to improve, but its revenue to decline.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
QDEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.90 | — |
| Q3 2026 | -$5.44 | +$11.84 |
| Q2 2026 | -$15.44 | -$8.64 |
| Q1 2026 | -$17.85 | -$12.62 |
| Q4 2025 | -$16.69 | +$13.85 |
| Q3 2025 | -$17.28 | +$10.61 |
| Q2 2025 | -$6.80 | +$20.98 |
| Q1 2025 | -$5.23 | +$21.15 |
| Q4 2024 | -$30.54 | -$30.39 |
QDEL has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over QDEL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
QDEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $618.9M | -12% |
| Q2 2026 | $630.9M | +2.8% |
| Q1 2026 | $619.8M | -11% |
| Q4 2025 | $723.6M | +2.2% |
| Q3 2025 | $699.9M | -3.7% |
| Q2 2025 | $613.9M | -3.6% |
| Q1 2025 | $692.8M | -2.6% |
| Q4 2024 | $707.8M | -4.7% |
QDEL's revenue has slid since its 2022 peak: $619M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.2% | +100 points |
| Q2 2026 | -3.5% | +26 points |
| Q1 2026 | -5.1% | -9.8 points |
| Q4 2025 | -9.2% | +5 points |
| Q3 2025 | -101% | -103 points |
| Q2 2025 | -29% | -11 points |
| Q1 2025 | 4.7% | +252 points |
| Q4 2024 | -14% | -20 points |
QDEL has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over QDEL on cash generation, producing positive trailing cash flow while its opponent burns cash.
QDEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$93.3M |
| Q2 2026 | -$136.1M | -$51.8M |
| Q1 2026 | -$67M | -813% |
| Q4 2025 | $86.6M | +425% |
| Q3 2025 | -$94.7M | -233% |
| Q2 2025 | -$84.3M | +$48.9M |
| Q1 2025 | $9.4M | +$76.2M |
| Q4 2024 | $16.5M | -48% |
QDEL's free cash flow was −$118M over the past year, against −$153M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
QDEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.3x | High |
| Q2 2025 | 11.9x | High |
| Q1 2025 | 8.6x | High |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.9x | Elevated |
| Q2 2023 | 3.8x | Elevated |
| Q1 2023 | 3.5x | Elevated |
| Q4 2022 | 2.3x | Moderate |
QDEL's net debt is about 8.3 years of its operating earnings (EBITDA), up from 3.9 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
QDEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 20.9 | Neutral |
QDEL's weekly RSI is 39 (neutral) and its Stochastic is 21 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
QDEL PE vs Healthcare Sector
| Metric | QDEL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
QDEL has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
QDEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 12% below |
| 20 week MA | $13.8 | 23% below |
| 50 week MA | $17.5 | 39% below |
| 100 week MA | $24.8 | 57% below |
| 200 week MA | $43.7 | 76% below |
QDEL is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over QDEL on returns for 2026, with the stronger performance.
QDEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.3 | $197.5 | +166% |
| 2021 | $197.5 | $137.4 | -30% |
| 2022 | $137.4 | $84.7 | -38% |
| 2023 | $84.7 | $73.7 | -13% |
| 2024 | $73.7 | $44.3 | -40% |
| 2025 | $44.3 | $29.3 | -34% |
| 2026 YTD | $29.3 | $10.6 | -64% |
QDEL has finished five years in a row lower, and it's down 64% so far in 2026.